Photoactivatable aggregation‐induced emission luminogens based on photodehydrogenation reactions for biomedical applications

Abstract The development of photoactivatable aggregation‐induced emission (AIE) probes is one of the hotspots for bioimaging and imaging‐guided precise disease therapy due to the distinct advantages of high spatiotemporal resolution, precise spatiotemporal controllability, and noninvasiveness of light. To design and develop novel photoactivatable AIE probes, functional groups based on photodehydrogenation reaction mechanisms are combined with the AIE‐active skeleton. Here, the recent progress in biomedical applications of photoactivatable AIE probes based on photocyclodehydrogenation and photo‐oxidative dehydrogenation reactions are summarized briefly. Moreover, the outlook for photoactivatable AIE probes is discussed to aim at promoting innovative research in biomedical applications.